Health Insurers Need BPaaS to Weather Post-Pandemic Conditions (First of a Multipart Series)
If you believe the headlines, health insurers are enjoying surging profits that have exceeded forecasted levels, even as other healthcare sectors struggle amid the COVID-19 pandemic. Most of these overly rosy assessments overlook short-term factors such as how rising unemployment numbers could reduce revenues from plan premiums. Even more important, these reports don’t reflect the […]Read More
Value-Based Care in Life Sciences: What’s It Worth to You?
Just one of the many changes rippling through the life sciences industry is the gradual but inexorable shift of value-based care (VBC) becoming a leading means of healthcare insurance reimbursement. According to our recently sponsored research, as many as 150 biopharmaceutical drugs are covered by value-based contracts, with a projected growth rate of 15% to […]Read More
Disaggregation of Healthcare: The Great Unbundling Proceeds
In discussions with our clients, it’s become apparent that one of the greatest changes we’re witnessing in healthcare is the disaggregation (or unbundling) of care. Historically, access to and delivery of healthcare took place primarily in doctors’ offices, hospitals and clinics. However, changes in consumer sentiment and advances in technology are creating a far more […]Read More
MACRA: Mapping a Path to Sustainable Value-Based Care
Given the flux in the healthcare industry and regulatory shifts from the Center for Medicare and Medicaid Services (CMS), it’s difficult to envision what the industry will look like in three to five years. Based on our visioning studies, however, we’re confident that value-based care will be the industry’s organizing principle. We’re also convinced that the […]Read More